Escolar Documentos
Profissional Documentos
Cultura Documentos
Disclaimer
Sales
+1,247.4 (26.6%)
Gross Profit
+75.2 (18.5%)
5,943.5
406.5
4,696.1
2011.1Q
481.7
2012.1Q
2011.1Q
Operating Profit
+8.2 (4.9% )
174.6
166.4
2011.1Q
2012.1Q
2012.1Q
139.5
2011.1Q
130.6
2012.1Q
Construction Sales
2011.1Q
Building
2012.1Q
Change
(%)
9.2(Target)
Civil
Plant
Housing
Building
698.7
801.2
102.5
14.7%
Civil
364.7
394.0
29.3
8.0%
Plant
205.2
423.8
218.6
106.5%
Housing
231.1
309.7
78.6
34.0%
Total
1,499.7
1,928.7
429.0
28.6%
Domestic
1,175.0
1,331.6
156.6
13.3
Overseas
324.7
597.1
272.4
83.9
1,928.7
1,499.7
46.6%
41.5%
28.6%
20.4%
24.3%
22.0%
13.7%
15.4%
2011.1Q
16.1%
2012.1Q
+69.7 (37.4%)
13.3%
12.4%
7.3%
5.8%
256.2
186.5
112.5
109.9
2011.1Q
2012.1Q
2011.1Q
2012.1Q
New Orders
Building
87.5
16tn
388.0
Civil
Qatar Lusail Road
334.5
2.3tn
Domestic
7.4tn
2012 Target
2012 Target
Overseas
0.5tn
Domestic
1.8tn
Housing
Segok Dong 2-3 Apt
105.6
700.0
2012. 1Q
2012.1Q
Orders Backlog
Ach. Rate
End of 2011
2012.1Q
Change
Building
4,800.0
890.9
18.6%
Building
5,285.1
5,374.8
1.7%
Civil
3,000.0
398.6
13.3%
Civil
4,629.7
4,634.3
0.1%
Plant
5,200.0
85.1
1.6%
Plant
8,049.1
7,710.4
4.2%
Housing
3,000.0
932.6
31.1%
Housing
13,616.8
14,258.2
4.7%
Total
16,000.0
2,307.2
14.4%
Total
31,580.7
31,977.7
1.3%
Domestic
7,437.5
1,777.3
23.9%
Domestic
21,471.7
21,935.9
2.2%
Overseas
8,562.5
529.9
6.2%
Overseas
10,109.0
10,041.8
0.7%
T&I Sales
Industrial
Materials
2011.1Q
2012.1Q
Change
(%)
17.8tn(Target)
47% 53%
Natural
Resources
Energy
Environment
4,014.8
3,196.4
Industrial
Materials
2,659.1
2,995.9
336.8
12.7%
Natural
Resources
464.5
902.0
437.5
94.2%
Energy &
Environment
72.8
116.9
44.1
60.6%
Total
3,196.4
4,014.8
818.4
25.6%
HQ
1,489.9
1,635.1
145.2
9.7%
Overseas
1,706.5
2,379.7
673.2
39.4%
74.6%
83.2%
25.6%
22.5%
14.5%
2.3%
2011.1Q
2.9%
2012.1Q
6. 2011_T&I Profit
8
(bn KRW)
+5.5 (2.5%)
+5.6 (9.9%)
6.9%
5.6%
1.8%
1.5%
225.5
220.0
62.1
56.5
2011.1Q
2012.1Q
2011.1Q
2012.1Q
7. Others
9
(bn KRW)
Dividend Profit
5.7 (12.5%)
Total/Net Debt
Other Affiliates
Samsung Electronics
Others
Total
56.0
4,994.9
8.6
Total
29.2
4,230.7
29.2
45.5
23.0
6.1
39.8
15.6
27.4
24.4
Net
29.9
Net
3,228.5
3,790.1
9.9
29.9
4.3
2011.1Q
2012.1Q
2011.1Q
2012.1Q
End of 2011
2012.1Q
Const.
2011. 1Q
T&I
Total
Const.
2011
T&I
Total
Const.
T&I
5,943.5
1,928.7
4,014.8
4,696.1
1,499.7
3,196.4
21,545.6
7,313.8
14,231.8
Gross Profit
481.7
256.2
225.5
406.5
186.5
220.0
1,702.3
904.2
798.1
SG&A
388.0
174.5
213.5
288.5
123.3
165.2
1,351.6
637.1
714.5
80.9
30.8
50.1
48.4
46.7
1.7
246.2
131.3
114.9
174.6
112.5
62.1
166.4
109.9
56.5
596.9
398.4
198.5
Other Profit
Operating
Profit
Profit before
income tax
Profit for the
Period
179.7
198.3
610.0
130.6
139.5
409.1
2012. 1Q
Total
Const.
2011. 1Q
T&I
Total
Const.
2011
T&I
Total
Const.
T&I
GP Margin
8.1%
13.3%
5.6%
8.7%
12.4%
6.9%
7.9%
12.4%
5.6%
OP Margin
2.9%
5.8%
1.5%
3.5%
7.3%
1.8%
2.8%
5.4%
1.4%
SG&A(%)
6.5%
9.0%
5.3%
6.1%
8.2%
5.2%
6.3%
8.7%
5.0%
Profit before
income tax (%)
Profit for the
Period (%)
3.0%
4.2%
2.2%
3.0%
2.8%
1.9%
End of 2011
(A)
Total Assets
End of 2010
(B)
Change
(A-B)
23,794.9
20,922.0
2,872.9
9,343.3
8,146.3
1,197.0
14,451.6
12,775.7
1,675.9
13,272.3
11,436.9
1,835.4
Current liabilities
8,290.9
7,447.8
843.1
Non-current liabilities
4,981.4
3,989.1
992.3
10,522.6
9,485.1
1,037.5
10,420.0
9,385.0
1,035.0
102.6
100.1
2.5
126%
121%
5%p
Current assets
Non-current assets
Total Liabilities
Total Equity
Equity attributable to owners
of the parent
Non-controlling interests
Shares
(Thousand)
Purchase Price
Book value
End of 2012.1Q
Samsung Electronics
4.06%
5,976
1,275,000
395.1
7,619.9
Cheil Worldwide
12.64%
14,539
18,100
20.6
263.2
Samsung Techwin
4.28%
2,273
68,000
28.3
154.6
5.59%
1,442
54,500
34.0
78.6
Samsung Card
2.39%
2,942
39,450
104.0
116.1
Samsung Securities
0.26%
202
56,800
4.5
11.5
38.68%
18,954
n/a
116.6
458.7
Samsung Petrochemical
27.27%
1,082
n/a
37.2
130.7
Samsung Everland
1.48%
37
n/a
3.4
67.4
*Samsung Biologics
10.44%
774
n/a
38.1
38.1
18.29%
13,216
n/a
180.4
817.8
962.2
9,786.4
Listed
NonListed
Total
* Samsung Biologics: Purchase price expected to increase to 61.2bn KRW by August 2013, due to the decision to participate in capital increase
of Samsung Biologics
Thank you
This material is prepared by Samsung C&T Corporation for its shareholders and candidate investors as Information
for reference only and is not intended to give any guideline or information to make any decision. Certain section(s)
of this document contain forward-looking statements that are based on expectations, estimations and assumptions
of Samsung C&T Corporation and outside organizations, and therefore, please be advised that any projections or
estimates may be different from actual results and that Samsung C&T Corporation does not make any representation
or warranty either expressly or implicitly as to the correctness, completeness and accuracy hereof.
Samsung C&T Corporation shall not be liable for any direct, indirect, consequential, incidental or special damages
due to your Reliance on the information
13